iPLA 2 β: A novel store-operated calcium entry modulator contributing to muscle dysfunction during denervation
Science Advances · 2026
DOI: 10.1126/sciadv.aed1646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Hongyang Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Group VI Phospholipases A2, Calcium, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIA NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Sarcopenia, the age-related loss of skeletal muscle mass and strength, is a major cause of frailty and disability, with neuromuscular denervation as a key contributor. Bioactive lipid mediators, including lipid hydroperoxides and oxylipins, contribute to denervation-induced muscle atrophy and dysfunction. Here, we identify calcium-independent phospholipase A 2 β (iPLA 2 β) as a novel regulator of store-operated calcium ion (Ca 2+ ) entry (SOCE), a critical process for maintaining Ca 2+ homeostasis via stromal interaction molecule 1 (STIM1) and Orai1 coupling in skeletal muscle. Using muscle-specific iPLA 2 β knockout (miPLA 2 βKO) mice, we show that iPLA 2 β interacts with STIM1-Orai1 coupling to modulate SOCE. Denervation elevates iPLA 2 β, hyperactivating SOCE and causing Ca 2+ overload through oxidative impairment of regulators such as SERCA. iPLA 2 β deletion normalizes SOCE, preserves Ca 2+ homeostasis, and protects against denervation-induced muscle mass (5%) and strength loss (50%). These findings reveal that iPLA 2 β may be a critical link between oxidative stress and Ca 2+ dysregulation and a promising target for mitigating muscle dysfunction during denervation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
- Oklahoma City VA Medical Center, Oklahoma City, OK, USA.
- Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL, USA.
- Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom.
ORCID-Profile: Hongyang Xu, Shylesh Bhaskaran, Jacob Brown, Luis Gustavo Oliveira de Sousa, Constantin Georgescu, Elizabeth Duggan, Kara Kneuper, Victoria Tyrrell, Valerie B O'Donnell, Kenneth Humphries, Holly Van Remmen
Förderung
- BLRD VA
- NIA NIH HHS
- National Institute on Aging
- U.S. Department of Veterans Affairs
- Glenn Foundation for Medical Research
Zitieren
APA
Xu, H., Bhaskaran, S., Brown, J., de Sousa, L. G. O., Georgescu, C., Duggan, E., Kneuper, K., Bell, A., Thomason, J., Gamez-Rico, A., Hagy, B., Tyrrell, V., O'Donnell, V. B., Humphries, K., & Van Remmen, H. (2026). iPLA 2 β: A novel store-operated calcium entry modulator contributing to muscle dysfunction during denervation. Science Advances. https://doi.org/10.1126/sciadv.aed1646
Vancouver
Xu H, Bhaskaran S, Brown J, de Sousa LGO, Georgescu C, Duggan E, et al. iPLA 2 β: A novel store-operated calcium entry modulator contributing to muscle dysfunction during denervation. Science Advances. 2026. doi:10.1126/sciadv.aed1646
BibTeX
@article{Xu2026,
author = {Xu, Hongyang and Bhaskaran, Shylesh and Brown, Jacob and de Sousa, Luis Gustavo Oliveira and Georgescu, Constantin and Duggan, Elizabeth and Kneuper, Kara and Bell, Ashley and Thomason, Jessica and Gamez-Rico, Andy and Hagy, Bo and Tyrrell, Victoria and O'Donnell, Valerie B and Humphries, Kenneth and Van Remmen, Holly},
title = {iPLA 2 β: A novel store-operated calcium entry modulator contributing to muscle dysfunction during denervation},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aed1646}
}
EUVIMED